2022-RA-909-ESGO AGO-OVAR 28/ENGOT-ov57: niraparib vs niraparib in combination with bevacizumab in patients with carboplatin-taxane based chemotherapy in advanced ovarian cancer (a multicentre randomised phase III trial)

Florian Heitz; Christian Marth; Stéphanie Henry; Alexander Reuss; David Cibula; Lydia Gaba; Nicoletta Colombo; Sandra Polleis; Philipp Harter

doi:10.1136/ijgc-2022-ESGO.590

Article info

Ovarian cancer

2022-RA-909-ESGO AGO-OVAR 28/ENGOT-ov57: niraparib vs niraparib in combination with bevacizumab in patients with carboplatin-taxane based chemotherapy in advanced ovarian cancer (a multicentre randomised phase III trial)

Free

Authors

Florian Heitz AGO Study Group and Ev. Kliniken Essen-Mitte, Essen, Germany PubMed articles Google scholar articles
Christian Marth AGO-Austria and Medical University of Innsbruck, Innsbruck, Austria PubMed articles Google scholar articles
Stéphanie Henry BGOG and CHU UCL Namur Site Sainte Elisabeth, Namur, Belgium PubMed articles Google scholar articles
Alexander Reuss AGO Study Group and Coordinating Center for Clinical Trials, Philipps-University of Marburg, Marburg, Germany PubMed articles Google scholar articles
David Cibula CEEGOG and General University Hospital in Prague, Prague, Czech Republic PubMed articles Google scholar articles
Lydia Gaba GEICO and Hospital Clinic of Barcelona, Barcelona, Spain PubMed articles Google scholar articles
Nicoletta Colombo MANGO and IEO, European Institute of Oncology, IRCCS, Milan and University of Milano-Bicocca, Milan, Italy PubMed articles Google scholar articles
Sandra Polleis AGO Study Group, Wiesbaden, Germany PubMed articles Google scholar articles
Philipp Harter AGO Study Group and Ev. Kliniken Essen-Mitte, Essen, Germany PubMed articles Google scholar articles

Citation

Heitz F, Marth C, Henry S, et al

International Journal of Gynecologic Cancer 2022;32:A277.

Publication history

First published October 20, 2022.

Online issue publication

October 27, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password